Search Within

Samuel Singer

  1. "Biostatistics Service"
Formats
  1. Journal Article (64)
  2. Meeting Abstract (40)
Groups
  1. Biostatistics Service (104)
  2. Epidemiology and Biostatistics (104)
  3. GSK Faculty (104)
  4. Sarcoma Surgeons (104)
  5. Surgery (104)
  6. Tow Center for Developmental Oncology (TCDO) (104)

More Groups

People
  1. Li-Xuan Qin (82)
  2. Cristina Antonescu (51)
  3. Aimee Crago (39)
  4. Murray Brennan (38)
  5. William Tap (38)
  6. Mark Dickson (34)

More People

Years
  1. 2024 (8)
  2. 2023 (4)
  3. 2022 (8)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (7)

More Years

Publications
  1. Annals of Surgical Oncology (19)
  2. Journal of Clinical Oncology (19)
  3. Annals of Surgery (9)
  4. Clinical Cancer Research (9)
  5. Cancer Research (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. Springer (21)
  3. American Association for Cancer Research (14)
  4. Lippincott Williams & Wilkins (9)
  5. Nature Publishing Group (7)
  6. Oxford University Press (6)

More Publishers

Results (104)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A recurrent point mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma
    Meeting Abstract

    Kohsaka, S.; Shukla, N.; Ameur, N.; Lim, D. ; Viale, A.; Socci, N.; Qin, L. X.; Sciot, R.; Bridge, J.; Singer, S.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Association of perioperative radiation therapy with outcome in 204 patients with primary retroperitoneal sarcoma: A two-institution study
    Meeting Abstract

    Kelly, K. J.; Yoon, S. S.; Kuk, D.; Qin, L. X.; Dukleska, K.; Chang, K.; DeLaney, T. F.; Brennan, M. F.; Singer, S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Poor prognostic features in angiosarcoma: A single institution retrospective study of 324 patients
    Meeting Abstract

    D'Angelo, S. P.; Moraco, N. H.; Qin, L. X.; Kuk, D.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Antonescu, C. R.; Singer, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Final results of sequential phase 2 studies of palbociclib (PD0332991) in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M.; Tap, W. D.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; Singer, S.; Schwartz, G. K.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • High-risk features in radiation-associated breast angiosarcomas
    Journal Article

    D'Angelo, S. P.; Antonescu, C. R.; Kuk, D.; Qin, L.; Moraco, N.; Carvajal, R. D.; Chi, P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; more...
    British Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
    Journal Article

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; Condy, M. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A prognostic nomogram for prediction of recurrence in desmoid fibromatosis
    Journal Article

    Crago, A. M.; Denton, B.; Salas, S.; Dufresne, A.; Mezhir, J. J.; Hameed, M.; Gonen, M.; Singer, S.; Brennan, M. F.
    Annals of Surgery (2013)

    Fulltext@MSK | Save
  • Predictors of survival and recurrence in primary leiomyosarcoma
    Journal Article

    Gladdy, R. A.; Qin, L. X.; Moraco, N.; Agaram, N. P.; Brennan, M. F.; Singer, S.
    Annals of Surgical Oncology (2013)

    Fulltext@MSK | Save
  • Genomic and functional analysis of myxofibrosarcoma identifies HGF/MET and integrin alpha 10 as potential prognostic biomarkers and novel therapeutic targets
    Meeting Abstract

    Lee, A. Y.; Agaram, N. P.; Qin, L.; Crago, A. M.; O'Connor, R. B.; Socci, N. D.; Okada, T.; Singer, S.
    Annals of Surgical Oncology (2013)

    Fulltext@MSK | Save